High-dose quetiapine and therapeutic monitoring

被引：4
|
作者：
Javelot, Herve [1 ]
Rangoni, Francis [2 ]
Weiner, Luisa [3 ]
Michel, Bruno [4 ]
机构：
[1] Etab Publ Sante Alsace Nord, Serv Pharm Clin, Brumath, France
[2] Etab Publ Sante Alsace Nord, Pole G07, Brumath, France
[3] CHU Strasbourg, Civil Hosp, Psychiat 2, Strasbourg, France
[4] Hop Univ Strasbourg, Serv Pharm, Strasbourg, France
来源：
EUROPEAN JOURNAL OF HOSPITAL PHARMACY | 2019年 / 26卷 / 05期
关键词：
psychiatry; therapeutic drug monitoring; antipsychotics; quetiapine; resistant schizophrenia; PSYCHIATRY WFSBP GUIDELINES; BIOLOGICAL TREATMENT; WORLD FEDERATION; CYTOCHROME-P450; ENZYMES; ACTIVE METABOLITE; UPDATE; 2012; PHARMACOKINETICS; SCHIZOPHRENIA; VARIABILITY; MANAGEMENT;
D O I：
10.1136/ejhpharm-2018-001605
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Quetiapine is an atypical antipsychotic with a good safety profile permitting its administration beyond the maximum dose of 800 mg/day. We report the case of a patient with a resistant schizophrenia treated with high doses of quetiapine (up to 2000 mg/day) combined with drug monitoring and with favourable therapeutic response and tolerance.
引用
收藏
页码：285 / 287
页数：3
相关论文
共 50 条
  • [41] Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders
    Gerlach, M.
    Huennerkopf, R.
    Rothenhoefer, S.
    Libal, G.
    Burger, R.
    Clement, H.-W.
    Fegert, J. M.
    Wewetzer, Ch
    Mehler-Wex, C.
    PHARMACOPSYCHIATRY, 2007, 40 (02) : 72 - 76
  • [42] Therapeutic drug monitoring of quetiapine and its major metabolites quetiapine-sulfoxide and 7-hydroxy-quetiapine
    Schwarz, MJ
    Spellmann, I
    Muller-Arends, A
    Dehning, S
    Musil, R
    Opgen-Rhein, MO
    Zach, J
    Li, HD
    Müller, N
    Möller, HJ
    Riedel, M
    EUROPEAN PSYCHIATRY, 2005, 20 : S209 - S209
  • [43] THE THERAPEUTIC USE OF TRIIODOTHYRONINE AND HIGH-DOSE THYROXINE IN PSYCHIATRIC-DISORDER
    WHYBROW, PC
    ACTA MEDICA AUSTRIACA, 1994, 21 (02) : 47 - 52
  • [44] Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring
    Cojutti, Pier Giorgio
    Merelli, Maria
    Allegri, Lorenzo
    Damante, Giuseppe
    Bassetti, Matteo
    Pea, Federico
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (01) : 266 - 269
  • [45] Therapeutic Drug Monitoring of High-dose Sulbactam in Pediatric Patients: Preliminary Data From a Prospective Observational Pharmacokinetic Study
    Charoenwong, Kankamol
    Wacharachaisurapol, Noppadol
    Sukkummee, Warumphon
    Sophonphan, Jiratchaya
    Suchartlikitwong, Pintip
    Chatsuwan, Tanittha
    Anugulruengkitt, Suvaporn
    Puthanakit, Thanyawee
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2025, 44 (03) : 207 - 213
  • [46] Therapeutic Drug Monitoring, Population Pharmacokinetics Models, and External Validation of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia
    Maximova, Natalia
    Calabro, Pasquale Fabio
    Cangialosi, Alice
    Di Paolo, Antonello
    CHEMOTHERAPY, 2024,
  • [47] THERAPEUTIC USEFULNESS OF HIGH-DOSE OCTREOTIDE IN THE MANAGEMENT OF SEVERE NECROTIZING PANCREATITIS
    GUARNER, L
    PUIGDIVI, V
    BORRUEL, N
    ALVAREZ, A
    MALAGELADA, JR
    GASTROENTEROLOGY, 1995, 108 (04) : A357 - A357
  • [48] ERYTHEMAL AND THERAPEUTIC RESPONSE OF PSORIASIS TO PUVA USING HIGH-DOSE UVA
    SPEIGHT, EL
    FARR, PM
    BRITISH JOURNAL OF DERMATOLOGY, 1994, 131 (05) : 667 - 672
  • [49] Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris
    Rajendra, Narasimharajapura S.
    Ireland, Sheila
    George, Jacob
    Belch, Jill J. F.
    Lang, Chim C.
    Struthers, Allan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (08) : 820 - 828
  • [50] High-dose pentazocine antagonizes the antinociception induced by high-dose morphine
    Shu, Haihua
    Wang, Zhao
    Ye, Fang
    Li, Qiaobo
    Dou, Yunling
    Lin, Yibin
    Huang, Wenqi
    Xiao, Xiaoshan
    LIFE SCIENCES, 2015, 130 : 1 - 6
12345